RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 68 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $36,000 | -28.0% | 1,477 | -73.2% | 0.00% | – |
| Q4 2020 | $50,000 | +455.6% | 5,513 | +231.7% | 0.00% | – |
| Q3 2020 | $9,000 | -50.0% | 1,662 | -41.8% | 0.00% | – |
| Q2 2020 | $18,000 | -57.1% | 2,856 | -35.6% | 0.00% | – |
| Q4 2019 | $42,000 | +75.0% | 4,437 | +45.0% | 0.00% | – |
| Q3 2019 | $24,000 | -47.8% | 3,060 | +3.9% | 0.00% | – |
| Q2 2019 | $46,000 | +1433.3% | 2,944 | +1621.6% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 171 | +103.6% | 0.00% | – |
| Q3 2018 | $2,000 | – | 84 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $41,187,000 | 42.64% |
| Flagship Pioneering Inc. | 38,296,526 | $602,404,000 | 26.08% |
| HARBOURVEST PARTNERS LLC | 1,973,756 | $31,048,000 | 5.81% |
| Artal Group S.A. | 2,833,791 | $44,576,000 | 1.80% |
| EcoR1 Capital, LLC | 463,152 | $7,285,000 | 0.74% |
| Cormorant Asset Management, LP | 600,000 | $9,438,000 | 0.54% |
| Nikko Asset Management Americas, Inc. | 1,254,158 | $19,728,000 | 0.39% |
| Leap Investments LP | 14,100 | $222,000 | 0.30% |
| ARK Investment Management | 698,402 | $10,986,000 | 0.28% |
| Baillie Gifford | 4,234,682 | $66,612,000 | 0.07% |